These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [How great is the risk of malignancy from immunosuppressives?]. Sodomann CP; Gropp C Internist (Berl); 1979 Dec; 20(12):571-84. PubMed ID: 398353 [No Abstract] [Full Text] [Related]
25. [Dangers and limits of immunosuppressive therapy in chronic kidney diseases]. Schwaar R; Natusch R; Scholz D Dtsch Gesundheitsw; 1971 May; 26(19):868-71. PubMed ID: 5578166 [No Abstract] [Full Text] [Related]
26. [Long-term use of immunosuppressants in patients with kidney transplants]. Barbanel C; Kreis H; Crosnier J Ann Med Interne (Paris); 1975 Feb; 126(2):69-74. PubMed ID: 820233 [TBL] [Abstract][Full Text] [Related]
27. [Effect of immunosuppressants on lipids]. Pouteil-Noble C; Guebre F Nephrologie; 2000; 21(7):369-72. PubMed ID: 11200615 [No Abstract] [Full Text] [Related]
28. [Late results after kidney transplantation]. Linder E; Wegmann W Bull Schweiz Akad Med Wiss; 1970 Jun; 26(1):70-80. PubMed ID: 4395552 [No Abstract] [Full Text] [Related]
29. Immunosuppression and malignant neoplasms. Starzl TE; Penn I; Halgrimson CG N Engl J Med; 1970 Oct; 283(17):934. PubMed ID: 4917727 [No Abstract] [Full Text] [Related]
30. Risks of allogeneic hand transplantation. Baumeister S; Kleist C; Döhler B; Bickert B; Germann G; Opelz G Microsurgery; 2004; 24(2):98-103. PubMed ID: 15038013 [TBL] [Abstract][Full Text] [Related]
31. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216 [No Abstract] [Full Text] [Related]
32. Bilateral femoral capital avascular necrosis in a renal transplant recipient on tacrolimus-based immunosuppression. Nayagam LS; Rajan SG; Khandelwal N; Sen R; Kohli HS; Sud K; Gupta KL; Sakhuja V; Jha V Nephrol Dial Transplant; 2005 Oct; 20(10):2262-4. PubMed ID: 16030048 [No Abstract] [Full Text] [Related]
33. [Mycotic complications in immunosuppressive treatment]. Meinhof W Mykosen; 1970 Sep; 13(9):423-6. PubMed ID: 5474925 [No Abstract] [Full Text] [Related]
34. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.8. Cardiovascular risks. Immunosuppressive therapy. EBPG Expert Group on Renal Transplantation Nephrol Dial Transplant; 2002; 17 Suppl 4():30-1. PubMed ID: 12091636 [TBL] [Abstract][Full Text] [Related]
35. [Tongue haematoma after difficult intubation facilitated by the presence of an subclinical tumor]. Sueur G; Baert O; Rozada P; Rezig N; Dureuil B Ann Fr Anesth Reanim; 2009 Sep; 28(9):808-9. PubMed ID: 19695827 [No Abstract] [Full Text] [Related]
39. [Organ transplantation in the United States, 1968]. Greep JM; van der Heyde MN; Terpstra JL Ned Tijdschr Geneeskd; 1969 Apr; 113(14):626-30. PubMed ID: 4889690 [No Abstract] [Full Text] [Related]